×

Correction factor testing using frequent blood glucose input

  • US 8,208,984 B2
  • Filed: 03/09/2010
  • Issued: 06/26/2012
  • Est. Priority Date: 01/24/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising:

  • receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor;

    receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus;

    determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus; and

    cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.

View all claims
  • 9 Assignments
Timeline View
Assignment View
    ×
    ×